M3-Brigade Acquisition V Corp. (NASDAQ:MBAV) Short Interest Update

M3-Brigade Acquisition V Corp. (NASDAQ:MBAV) saw a significant drop in short interest in the month of February. As of February 13th, there was short interest totaling 32,579 shares, a drop of 40.4% from the January 29th total of 54,620 shares. Based on an average daily volume of 26,661 shares, the days-to-cover ratio is presently 1.2 days. Currently, 0.1% of the company’s stock are sold short. Currently, 0.1% of the company’s stock are sold short. Based on an average daily volume of 26,661 shares, the days-to-cover ratio is presently 1.2 days.

Insider Activity at M3-Brigade Acquisition V

In related news, major shareholder Fitzgerald & Co. Cantor bought 3,529,081 shares of the firm’s stock in a transaction dated Wednesday, December 17th. The stock was bought at an average price of $10.80 per share, with a total value of $38,114,074.80. Following the completion of the transaction, the insider directly owned 7,779,865 shares of the company’s stock, valued at approximately $84,022,542. This represents a 83.02% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Institutional Investors Weigh In On M3-Brigade Acquisition V

Several hedge funds and other institutional investors have recently modified their holdings of MBAV. Levin Capital Strategies L.P. bought a new position in shares of M3-Brigade Acquisition V during the second quarter worth about $538,000. Wealthspring Capital LLC bought a new position in M3-Brigade Acquisition V during the second quarter worth $2,715,000. MMCAP International Inc. SPC acquired a new position in M3-Brigade Acquisition V in the second quarter worth $16,935,000. Geode Capital Management LLC acquired a new position in M3-Brigade Acquisition V in the second quarter worth $1,978,000. Finally, Alberta Investment Management Corp bought a new stake in M3-Brigade Acquisition V during the second quarter valued at $27,943,000.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of M3-Brigade Acquisition V in a research report on Monday, December 22nd. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has an average rating of “Sell”.

M3-Brigade Acquisition V Stock Up 0.4%

Shares of MBAV stock traded up $0.05 during mid-day trading on Monday, reaching $10.73. 901 shares of the company were exchanged, compared to its average volume of 47,199. The business’s 50 day simple moving average is $10.66 and its 200 day simple moving average is $10.61. M3-Brigade Acquisition V has a fifty-two week low of $10.16 and a fifty-two week high of $13.73.

About M3-Brigade Acquisition V

M3-Brigade Acquisition V is a special purpose acquisition company (SPAC) sponsored by M3 Inc, a global healthcare information and technology provider, and Brigade Capital Management, an investment management firm. The company is structured as a blank‐check vehicle listed on the Nasdaq Stock Market under the ticker MBAV, with the objective of identifying and completing a business combination in the healthcare, life sciences or related sectors.

The company benefits from the operational expertise of M3’s digital health platform and real‐world data capabilities, combined with Brigade’s deep experience in credit and asset management.